Dosing effects of an antiosteoporosis herbal formula – a preclinical investigation using a rat model

Herba Epimedii, Fructus Ligustri Lucidi and Fructus Psoraleae are three frequently used Chinese herbs traditionally used for tonifying the ‘kidney system’. They were selected for the present study to formulate an herbal preparation with a weight ratio of 5:4:1 based on their phytochemical, nature, documented treatment efficacy and toxicity. The dosing effects (1 g/day, 0.5 g/day and 0.175 g/day) of the antiosteoporosis function of the water extract of this formula were tested in ovariectomy‐ and calcium deficiency‐induced osteoporotic rats. Eleven weeks of herbal treatment demonstrated a beneficial effect on the preservation of bone mineral density (BMD) at the femur neck in a dose‐dependent manner with the preference for higher dosage. No significant increase in uterus weight was observed in the herbal formula treated rats. In addition, microarray data of kidney tissue revealed that this herbal formula was able to down‐regulate the expression of phase II drug metabolizing enzymes, similar to the effects of estrogens. Copyright © 2007 John Wiley & Sons, Ltd.

[1]  L. Qin,et al.  Phytoestrogen-rich herb formula “XLGB” prevents OVX-induced deterioration of musculoskeletal tissues at the hip in old rats , 2009, Journal of Bone and Mineral Metabolism.

[2]  P. Leung,et al.  Flavonoids derived from herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. , 2006, Bone.

[3]  B. Potter,et al.  17β-Hydroxysteroid dehydrogenase Type 1 and Type 2: Association between mRNA expression and activity in cell lines , 2006, Molecular and Cellular Endocrinology.

[4]  Chunfu Wu,et al.  Effects of Fructus Ligustri Lucidi extract on bone turnover and calcium balance in ovariectomized rats. , 2006, Biological & pharmaceutical bulletin.

[5]  N. Udagawa,et al.  Prostaglandin E2 strongly inhibits human osteoclast formation. , 2005, Endocrinology.

[6]  T. Jiang,et al.  Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. , 2005, Kidney international.

[7]  J. Mccormack,et al.  Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells , 2005, The FEBS journal.

[8]  P. Leung,et al.  PREVENTION AND TREATMENT OF OSTEOPOROSIS WITH TRADITIONAL HERBAL MEDICINE , 2005 .

[9]  M. Loda,et al.  Kallikrein 4 is a Predominantly Nuclear Protein and Is Overexpressed in Prostate Cancer , 2004, Cancer Research.

[10]  D. Lubahn,et al.  In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens. , 2004, Endocrinology.

[11]  P. Leung,et al.  Beneficial effects of regular Tai Chi exercise on musculoskeletal system , 2004, Journal of Bone and Mineral Metabolism.

[12]  R. Prince,et al.  Effects of a herbal extract on the bone density, strength and markers of bone turnover of mature ovariectomized rats. , 2003, The American journal of Chinese medicine.

[13]  A. Kong,et al.  Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. , 2002, Current drug metabolism.

[14]  S. Narumiya,et al.  Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Wang,et al.  Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids. , 2001, Planta medica.

[16]  J. Clements,et al.  Kallikrein 4 (KLK4), a new member of the human kallikrein gene family is up-regulated by estrogen and progesterone in the human endometrial cancer cell line, KLE. , 2001, The Journal of clinical endocrinology and metabolism.

[17]  J. Aubin,et al.  Osteoprotegerin and its Ligand: A New Paradigm for Regulation of Osteoclastogenesis and Bone Resorption , 2000, Osteoporosis International.

[18]  J. Girard,et al.  Developmental changes in mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene expression in rat liver, intestine and kidney. , 1993, The Biochemical journal.